Podcast appearances and mentions of Jeffrey A Singer

Surgeon and author Jeffrey A. Singer discusses his article "The FDA's outdated prescription rules are failing women and opioid users." He argues that the U.S. Food and Drug Administration's requirement for prescriptions for certain safe medications, specifically hormonal contraceptives and the opioid antidote naloxone, creates significant barriers to access and reflects outdated paternalism. Jeffrey highlights that obtaining prescriptions for birth control pills adds cost and inconvenience, disproportionately affecting women who report difficulty accessing appointments, despite decades of recommendations from major medical groups like the American College of Obstetrics and Gynecology and the American Medical Association for over-the-counter access, a standard in over 100 countries. He critiques the FDA's slow and partial move to allow only one type of progestin-only "mini-pill" over-the-counter, contrasting it with the easier access to emergency contraception. Similarly, Jeffrey discusses the years-long delay in making naloxone available over-the-counter, despite its proven safety, effectiveness by laypeople, availability in other countries, and requests from experts and even the FDA itself, noting how manufacturer financial incentives and state-level workarounds preceded the eventual, partial FDA approval for the nasal spray form. Our presenting sponsor is Microsoft Dragon Copilot. Microsoft Dragon Copilot, your AI assistant for clinical workflow, is transforming how clinicians work. Now you can streamline and customize documentation, surface information right at the point of care, and automate tasks with just a click. Part of Microsoft Cloud for Healthcare, Dragon Copilot offers an extensible AI workspace and a single, integrated platform to help unlock new levels of efficiency. Plus, it's backed by a proven track record and decades of clinical expertise—and it's built on a foundation of trust. It's time to ease your administrative burdens and stay focused on what matters most with Dragon Copilot, your AI assistant for clinical workflow. VISIT SPONSOR → https://aka.ms/kevinmd SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

As government regulations increasingly encroach upon personal health care choices, patients face growing limitations on their ability to make their own decisions. In Your Body, Your Health Care, Dr. Jeffrey A. Singer validates these frustrations while presenting a bold philosophical framework for reforming the relationship between individuals, the health care system, and the state.Through thoughtful analysis of issues like prescription requirements, self-medication rights, harm-reduction access, and licensing laws, Dr. Singer outlines a path toward health care policy that prioritizes individual rights and adult autonomy.Please join us in discussing the book and its transformative implications with the author. Hosted on Acast. See acast.com/privacy for more information.

Introduction: Caleb O. Brown Erica York and Scott Lincicome on trade and globalization Senator Rand Paul and Caleb O. Brown on the demagoguery of protectionism Robert F. Bauer and John Samples on restoring political ethicsMartin A. Makary and Jeffrey A. Singer on groupthink and its effect on modern medicine Exclusive: Romina Boccia on spending and the debt Hosted on Acast. See acast.com/privacy for more information.

Joining A.J. Reid Finlayson, a psychiatrist, Jeffrey A. Singer, a general surgeon, and Peter R. Martin, also a psychiatrist. We'll be discussing the case of Dr. Ralph Thomas Reach, an addiction medicine physician whose medical license was revoked, leading to legal troubles, and the broader issues surrounding addiction treatment and the role of the DEA. Tune in as we explore the barriers to medication-assisted treatment, the historical context of federal intervention in addiction treatment, and the implications for health care professionals and individuals struggling with substance use disorders. A.J. Reid Finlayson is a psychiatrist. Jeffrey A. Singer is a general surgeon. Peter R. Martin is a psychiatrist. They discuss the KevinMD article, "The DEA's war on addiction doctors." The white paper discussed on the show: "Cops practicing medicine" Our presenting sponsor is Nuance, a Microsoft company. Together, Microsoft and Nuance are leveraging their rich digital technology and advanced AI capabilities to tackle some of health care's biggest challenges. AI-driven technology promises to revolutionize patient and provider experiences with clinical documentation that writes itself. The Nuance Dragon Ambient eXperience, or DAX for short, is a voice-enabled solution that automatically captures patient encounters securely and accurately at the point of care. DAX Copilot combines proven conversational and ambient AI with the most advanced generative AI in a mobile application that integrates directly with your existing workflows. Physicians who use DAX have reported a 50 percent decrease in documentation time and a 70 percent reduction in feelings of burnout, and 85 percent of patients say their physician is more personable and conversational. Discover AI-powered clinical documentation that writes itself. Visit https://nuance.com/daxinaction to see a 12-minute DAX Copilot demo. VISIT SPONSOR → https://nuance.com/daxinaction SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended GET CME FOR THIS EPISODE → https://earnc.me/R7utTf Powered by CMEfy.

The Rational Egoist: When the Badge Prescribes - A Discussion with Jeffrey A. Singer In an episode that bridges the gap between healthcare and law enforcement, The Rational Egoist welcomes Jeffrey A. Singer, a Senior Fellow at the Cato Institute specializing in Health Policy Studies, and a seasoned general surgeon with over 35 years of experience. This dialogue promises to unravel the complex issue of law enforcement's role in prescription decisions, a topic that has ignited considerable debate within both medical and legal communities. Jeffrey A. Singer brings his medical expertise and policy acumen to the table, shedding light on the unintended consequences that arise when the powers of law enforcement encroach upon the discretion of healthcare professionals. The conversation explores the delicate balance between controlling substance abuse and ensuring patients have access to necessary treatments without undue barriers. Listeners will gain insight into the historical context that led to this intersection of policing and prescribing, including the opioid crisis and its regulatory aftermath. Singer discusses the impact of these policies on patient care, pain management, and the doctor-patient relationship, highlighting stories from his extensive career that illustrate the human cost of well-intentioned but flawed interventions. The episode also delves into the broader implications of these practices on public health, civil liberties, and the erosion of medical autonomy. Through a critical examination of current policies and proposals for reform, Singer and Liebowitz engage in a thought-provoking discussion on how to navigate these challenges, safeguard patient rights, and restore the primacy of clinical judgment in medical practice. Join us on The Rational Egoist for a compelling episode with Jeffrey A. Singer, as we dissect the intricacies of when law enforcement makes prescription decisions. Whether you're a healthcare professional, a patient, or simply someone interested in the crossroads of policy, medicine, and law, this conversation offers valuable perspectives on a pressing issue facing our society today. Michael Leibowitz, host of The Rational Egoist podcast, is a philosopher and political activist who draws inspiration from Ayn Rand's philosophy, advocating for reason, rational self-interest, and individualism. His journey from a 25-year prison sentence to a prominent voice in the libertarian and Objectivist communities highlights the transformative impact of embracing these principles. Leibowitz actively participates in political debates and produces content aimed at promoting individual rights and freedoms. He is the co-author of “Down the Rabbit Hole: How the Culture of Correction Encourages Crime” and “View from a Cage: From Convict to Crusader for Liberty,” which explore societal issues and his personal evolution through Rand's teachings.Explore his work and journey further through his books:“Down the Rabbit Hole”: https://www.amazon.com.au/Down-Rabbit-Hole-Corrections-Encourages/dp/197448064X“View from a Cage”: https://books2read.com/u/4jN6xj

If you think that there's something necessary or good about medical licensing, you might want to tune in to this episode. In it, independent journalist Jeremy R Hammond and I demolish some of the myths around medical licensing. You might be surprised by what you hear.Jeremy's articles on "Why Medical Licensing Should be Eliminated" can be found here and here.And here is some of the analysis we referenced:Ronald Hamowy, “The Early Development of Medical Licensing Laws in the United States, 1875-1900”, Journal of Libertarian Studies, 1979, . Sue A. Blevins, “The Medical Monopoly: Protecting Consumers or Limiting Competition?” Cato Institute Policy Analysis, December 15, 1995, . Charles H. Baron, “Licensure of Health Care Professionals: The Consumer's Case for Abolition”, American Journal of Law & Medicine, April 29, 2021, . Jeffrey A. Singer & Richard P. Menger, “The Coronavirus Pandemic Shows the Folly of Medical-Licensing Laws”, National Review, May 29, 2020,

In this revealing episode of "The Rational Egoist," host Michael Leibowitz teams up with Dr. Jeffrey A. Singer, a distinguished surgeon and senior fellow at the Cato Institute, to dissect the contentious landscape of decongestant regulations set by the FDA. Firstly, the pair undertake a comprehensive analysis of the transition from pseudoephedrine to phenylephrine. This shift, propelled by concerns of pseudoephedrine's use in manufacturing methamphetamine, culminated in the stigmatisation and reduced accessibility of a once commonly used decongestant. Leibowitz and Dr. Singer explore the repercussions of this policy, pointing to independent research from private companies that dispute the FDA's endorsement of phenylephrine's efficacy. The broader scope of their conversation tackles the alarming increase in methamphetamine-related issues since 2006, bringing to the limelight the iron law of prohibition which unveils a dark trail of intensified and potent forms of prohibited substances spurred by bans. Equally, the dialogue ventures into the labyrinthine journey to the over-the-counter approval of the Plan B morning-after pill, spotlighting the deeply entrenched ideologies that stalled its accessibility for years, illustrating a vivid picture of how dominating cultures can impose restrictions over individual bodily autonomy. Beyond the spirited exploration of governmental regulations and individual rights, Leibowitz shares snippets from his personal journey of transformation. From facing a 25-year prison sentence to emerging as a beacon in the libertarian and Objectivist communities, he embodies the resurgence through the adoption of reason, rational self-interest, and individualism. Michael Leibowitz is not only a philosopher and activist but also a compelling author, contributing significantly to the libertarian discourse through his works including “Down the Rabbit Hole: How the Culture of Correction Encourages Crime” and “View from a Cage: From Convict to Crusader for Liberty,” both presenting a deep dive into societal attitudes towards punishment and rehabilitation while offering an intimate portrayal of his philosophical and personal transformation. Embark on this intellectual exploration, guided by a host with a compelling life narrative rooted in Ayn Rand's philosophical doctrines. Leibowitz's journey, a true embodiment of overcoming adversity through embracing rational self-interest and moral philosophy, stands as a testament to the empowerment and upliftment achievable through such a path. For further insights into Michael Leibowitz's profound transformation and deep understanding of individual rights, consider purchasing his books available at the following links: “Down the Rabbit Hole”: https://www.amazon.com.au/Down-Rabbit-Hole-Corrections-Encourages/dp/197448064X “View from a Cage”: https://books2read.com/u/4jN6xj Dive deep into a conversation that transcends the barriers of regulation, exploring the intricate interplay between governmental decisions and individual freedoms, only on "The Rational Egoist."

The Association of American Medical Colleges projects a shortage of as many as 48,000 primary care physicians by 2034. Yet there are not enough residency positions for the number of medical school graduates. Missouri became the first state to address this problem by launching a new licensure category: assistant physician (AP). APs are essentially apprentice physicians. The reform lets graduates without a residency position provide primary care in clinics while enhancing their knowledge and skills. Six other states have passed similar laws: Arkansas, Kansas, Utah, Arizona, Louisiana, and Idaho.Please join Kevin D. Dayaratna, PhD, a senior research fellow at the Heritage Foundation's Center for Data Analysis; Keith J. Frederick, DO, a former Missouri legislator who spearheaded the country's first AP law; and Lyman Wostrel, MD, a primary care physician practicing under Missouri's AP law, to discuss this issue. Cato Institute senior fellow Jeffrey A. Singer, MD, will moderate the discussion. Hosted on Acast. See acast.com/privacy for more information.

Jeffrey A. Singer is a senior fellow at the Cato Institute and works in the Department of Health Policy Studies. He is President Emeritus and founder of Valley Surgical Clinics Ltd., the largest and oldest group private surgical practice in Arizona, and has been in private practice as a general surgeon for more than 35 years. A Hippocratic Oath for a Free Society

Frank begins by asking listeners what their preferred tax methodology would be. Frank then speaks with Dr. Jeffrey A. Singer, senior fellow at the Cato Institute and works in the Department of Health Policy Studies. He is also the President Emeritus and founder of Valley Surgical Clinics Ltd., the largest and oldest group private surgical practice in Arizona, and has been in private practice as a general surgeon for more than 35 years. They discuss the fentanyl crisis in America and whether or not the U.S. should bomb Mexican drug cartels. After, Frank talks about Morgan Freeman saying in an interview that he is insulted by the term "African American" and then he goes to the mail. Later, Frank talks about the Mayor in Minneapolis allowing amplified call to prayer five times a day, and much more.   Learn more about your ad choices. Visit megaphone.fm/adchoices

Frank interviews Dr. Jeffrey A. Singer, senior fellow at the Cato Institute and works in the Department of Health Policy Studies. He is also the President Emeritus and founder of Valley Surgical Clinics Ltd., the largest and oldest group private surgical practice in Arizona, and has been in private practice as a general surgeon for more than 35 years. They discuss the fentanyl crisis in America and whether or not the U.S. should bomb Mexican drug cartels.  Learn more about your ad choices. Visit megaphone.fm/adchoices

As deaths from drug overdoses and drug‐​related diseases continue increasing, policymakers in cities across the United States have become more willing to consider implementing overdose prevention centers (OPCs) as the next step toward a more effective harm reduction strategy. For more than 30 years, OPCs have prevented overdose deaths, HIV and hepatitis, and other diseases and helped people with substance use disorder find treatment. OPCs, also known as safe consumption sites or drug consumption rooms, began in Europe in the mid‐​1980s. Governments and harm reduction organizations now operate OPCs in 16 developed countries, including many European countries, Canada, Mexico, and Australia. Unfortunately, a federal law that prosecutors and harm reduction opponents call the “crack house” statute makes them illegal in the United States. Yet New York City sanctions two such facilities in defiance of federal law.Joining us to discuss the worldwide experience with OPCs, and to share data and experiences at sanctioned OPCs in North America, are Chelsea Boyd, research fellow in the R Street Institute's integrated harm reduction program; Darwin Fisher, Senior Program Manager at PHS Community Services Society in Vancouver, British Columbia, and manager of Insite, North America's oldest sanctioned overdose prevention center; and Kailin See, Senior Director of Programs for OnPoint NYC and program and development lead for New York City's two sanctioned overdose prevention centers, the first approved OPCs in the United States. Cato Institute senior fellow Jeffrey A. Singer will moderate the discussion. Hosted on Acast. See acast.com/privacy for more information.

"Jeffrey A. Singer is a senior fellow at the Cato Institute and works in the Department of Health Policy Studies. He is President Emeritus and founder of Valley Surgical Clinics Ltd., the largest and oldest group private surgical practice in Arizona and has been in private practice as a general surgeon for more than 35 years. He is also a visiting fellow at the Goldwater Institute in Phoenix. Singer is a member of the Board of Scientific Advisors of the American Council on Science and Health. From 1994 to 2016, he was a regular contributor to Arizona Medicine, the journal of the Arizona Medical Association. He served on the Advisory Board Council of the Center for Political Thought and Leadership at Arizona State University from 2014 to 2018 and is an adjunct instructor in the Program on Political History and Leadership at ASU. He writes and speaks extensively on regional and national public policy, with a specific focus on the areas of health care policy and the harmful effects of drug prohibition. He received his BA from Brooklyn College (City University of New York) and his MD from New York Medical College. He is a fellow of the American College of Surgeons." Links to articles discussed in this podcast episode: Nitazenes Cops Practicing Medicine Dr. Singer's Twitter Dr. Josh Bloom's article about the Dr. Singer vs. Dr. Fugh-Berman debate Dr. Singer vs. Dr. Fugh-Berman debate Dr. Singer and Dr. Bloom's article discussing pain and tylenol Disclaimer: The information that has been provided to you in this podcast is not to be considered legal or medical advice. --- Send in a voice message: https://anchor.fm/the-doctor-patient-forum/message Support this podcast: https://anchor.fm/the-doctor-patient-forum/support

Rochelle Walensky, Director of the Centers for Disease Control and Prevention (CDC), said, “For 75 years, CDC and public health have been preparing for COVID-19, and in our big moment, our performance did not reliably meet expectations.” She announced plans to “reset” the agency by restructuring its communications team, changing its organizational structure, and emphasizing applied rather than academic scientific research.Where did the CDC fail, and where did it succeed in responding to the COVID pandemic? Did the agency's leadership suffer from politicization and groupthink? Is the Director's proposed “reset” enough of a reform? Are there other systematic agency failures that reformers should remedy? Joining us to discuss these and other questions are Martin A. Makary, MD, MPH, Professor of Surgery at Johns Hopkins University School of Medicine and Professor of Health Policy and Management at Johns Hopkins University Bloomberg School of Public Health; Ari N. Schulman, editor of The New Atlantis, and The New Atlantis Books; and Ronald A. Bailey, science correspondent for Reason Magazine and an adjunct scholar at the Cato Institute. The discussion will be moderated by Cato Institute senior fellow Jeffrey A. Singer, MD. Hosted on Acast. See acast.com/privacy for more information.

t his 2022 State of the Union address, President Biden focused the nation's attention on “a national mental health crisis.” Mood disorders and suicidal thoughts and behaviors have been rising at alarming levels for years. The pandemic and government‐​mandated lockdowns increased anxiety, isolation, and despair while also reducing access to mental health services. Approximately 40 percent of Americans currently cannot access mental health services, particularly services requiring drug‐​based therapy.Clinical psychologists can play a greater role in meeting those needs. Some federal agencies, five states, and the territory of Guam authorize competent clinical psychologists to prescribe medications that affect mood and mental functions. Those jurisdictions refer to such psychologists as prescribing psychologists, medical psychologists, or RxPs. However, most states prohibit competent clinical psychologists from prescribing such medication. To address the mental health crisis, should state lawmakers expand the scope of practice of competent clinical psychologists to include prescribing?Joining us to discuss this are Dr. Beth Rom‐​Rymer, a clinical psychologist, chair and president of the board of directors of the National Register of Health Service Psychologists, and CEO of the Illinois Association of Prescribing Psychologists; Dr. Rebecca Weintraub Brendel, an assistant professor of psychiatry at Harvard Medical School, director of the master's degree program at Harvard Medical School's Center for Bioethics, and president and distinguished fellow of the American Psychiatric Association; Dr. Thomas D. Lee, a psychiatrist at the Ascension Alexian Brothers Center for Mental Health in Arlington, Illinois, who supervises psychology fellows in the Ascension RxP Fellowship Program; and Dr. Claudia Mosier, a prescribing psychologist licensed in Illinois and Louisiana. The discussion will be moderated by Cato Institute senior fellow Jeffrey A. Singer, MD. Hosted on Acast. See acast.com/privacy for more information.

The Goldwater Institute's Christina Sandefur moderates a discussion with the Cato Institute's director of health care policy Michael F. Cannon, on the role that the federal government plays in requiring prescriptions for medications. If you would like to read more from Cannon, see his and Jeffrey A. Singer's white paper, Drug Reformation: End Government's Power to Require Prescriptions.Featuring:Michael F. Cannon, Director of Health Policy Studies, Cato Institute [Moderator] Christina Sandefur, Executive Vice President, Goldwater InstituteVisit our website – www.RegProject.org – to learn more, view all of our content, and connect with us on social media.

The virus that causes COVID-19 has now become endemic after it first emerged two and a half years ago. In the pandemic's early days, many countries' public health officials curtailed economic and social activity to various degrees, prescribed social distancing, enforced lockdowns, required masking, and pushed for other nonpharmaceutical interventions (NPIs) to reduce illness and death. Those NPIs imposed an enormous economic and social cost by greatly reducing individual liberty in exchange for promised health benefits. Elsewhere, most famously in Sweden, public health officials were fiercely criticized for implementing less‐​harsh “light touch” NPI measures. Sweden's approach presents a fascinating quasi‐​natural experiment to evaluate the merits and demerits of the more liberal approach to managing the COVID-19 pandemic and to evaluate whether the loss in personal and economic freedom was partly compensated by a decrease in illness and death. Sweden's outcomes on viral spread, excess mortality, and the socioeconomic consequences of COVID-19 compare well with other countries and suggest that strict NPI policies imposed more harm than good.Joining us to discuss how well Sweden's approach worked are Jeanne Lenzer, an independent investigative journalist and regular contributor to The BMJ who has studied this issue; Vinay Prasad, MD, MPH, an epidemiologist and public health policy analyst who is an associate professor at University of California San Francisco School of Medicine; Jay Bhattacharya, MD, PhD, professor of medicine at Stanford University School of Medicine and coauthor of the Great Barrington Declaration that urged a pandemic policy of “focused protection”; and Johan Norberg, senior fellow at the Cato Institute, who resides in Stockholm, Sweden, and has studied as well as experienced his country's pandemic policy. The discussion will be moderated by Cato Institute senior fellow Jeffrey A. Singer. Our GDPR privacy policy was updated on August 8, 2022. Visit acast.com/privacy for more information.

State‐​level drug paraphernalia laws increase the risk of infection or overdose for drug users by preventing legal access to clean needles, syringes, and products to test drugs for deadly contaminants. Every state except Alaska criminalizes the possession and/​or sale of illicit drug paraphernalia. Thus, Alaskans can legally operate needle exchange programs and other harm‐​reduction measures. Recognizing that harm‐​reduction strategies reduce overdoses and disease, many states are considering reforms to their drug paraphernalia laws. To discuss the impact of drug paraphernalia laws on health and how states can implement better rules, we are pleased to have Corey S. Davis, the director of the Harm Reduction Legal Project of the Network for Public Health Law and adjunct faculty at the Brody School of Medicine at East Carolina University; Robin Lutz, executive director of the Alaskan AIDS Assistance Association, which has provided harm‐​reduction services in Alaska since 1985; and Haley B. Coles, executive director of Sonoran Prevention Works, which has been engaged in harm‐​reduction and syringe services in Arizona since 2010. The discussion will be moderated by Cato Institute senior fellow Jeffrey A. Singer. See acast.com/privacy for privacy and opt-out information.

Jeffrey A. Singer is a senior fellow at the Cato Institute and works in the Department of Health Policy Studies. He is President Emeritus and founder of Valley Surgical Clinics Ltd., the largest and oldest group private surgical practice in Arizona, and has been in private practice as a general surgeon for more than 35 years.He is also a visiting fellow at the Goldwater Institute in Phoenix. Singer is a member of the Board of Scientific Advisors of the American Council on Science and Health. From 1994 to 2016, he was a regular contributor to Arizona Medicine, the journal of the Arizona Medical Association. He served on the Advisory Board Council of the Center for Political Thought and Leadership at Arizona State University from 2014 to 2018 and is an adjunct instructor in the Program on Political History and Leadership at ASU. He writes and speaks extensively on regional and national public policy, with a specific focus on the areas of health care policy and the harmful effects of drug prohibition.

"Don't believe the claim that the internet has corrupted our public discourse with misinformation," says Jeffrey A. Singer, a senior... The post How 'Cranks' Advance Science appeared first on Reason.com.

Introduction: Caleb O. BrownMike Tanner and Vanessa Brown Calder on housing regulations Gabriella Beaumont-Smith on letting solar tariffs dieU.S. Rep. Earl Blumenauer (OR), Dr. Carl L. Hart, and Dr. Jeffrey A. Singer on the overdose crisisChris Kemmitt of the NAACP Legal Defense Fund on public school administrators covered by qualified immunityDavid Boaz on why we need a movement for freedom See acast.com/privacy for privacy and opt-out information.

QUESTION PRESENTED:Whether a physician alleged to have prescribed controlled substances outside the usual course of professional practice may be convicted of unlawful distribution under 21 U.S.C. § 841(a)(1) without regard to whether, in good faith, he “reasonably believed” or “subjectively intended” that his prescriptions fall within that course of professional practice.Date                  Proceedings and Orders (key to color coding)Apr 05 2021 | Petition for a writ of certiorari filed. (Response due May 7, 2021)Apr 27 2021 | Motion to extend the time to file a response from May 7, 2021 to June 7, 2021, submitted to The Clerk.Apr 28 2021 | Motion to extend the time to file a response is granted and the time is extended to and including June 7, 2021.May 07 2021 | Brief amici curiae of Professors of Health Law and Policy filed.May 27 2021 | Motion to extend the time to file a response from June 7, 2021 to July 7, 2021, submitted to The Clerk.May 28 2021 | Motion to extend the time to file a response is granted and the time is further extended to and including July 7, 2021.Jul 07 2021 | Brief of respondent United States of America in opposition filed. VIDED.Jul 20 2021 | Reply of petitioner Xiulu Ruan filed. (Distributed)Jul 21 2021 | DISTRIBUTED for Conference of 9/27/2021.Oct 04 2021 | DISTRIBUTED for Conference of 10/8/2021.Oct 12 2021 | DISTRIBUTED for Conference of 10/15/2021.Oct 25 2021 | DISTRIBUTED for Conference of 10/29/2021.Nov 01 2021 | DISTRIBUTED for Conference of 11/5/2021.Nov 05 2021 | Petition GRANTED. The petition for a writ of certiorari in No. 21-5261 is granted. The cases are consolidated, and a total of one hour is allotted for oral argument.Nov 05 2021 | Because the Court has consolidated these cases for briefing and oral argument, future filings and activity in the cases will now be reflected on the docket of No. 20-1410. Subsequent filings in these cases must therefore be submitted through the electronic filing system in No. 20-1410. Each document submitted in connection with one or more of these cases must include on its cover the case number and caption for each case in which the filing is intended to be submitted. Where a filing is submitted in fewer than all of the cases, the docket entry will reflect the case number(s) in which the filing is submitted; a document filed in all of the consolidated cases will be noted as “VIDED.”Dec 08 2021 | Blanket Consent filed by Petitioner, Xiulu RuanDec 17 2021 | ARGUMENT SET FOR Tuesday, March 1, 2022. VIDED.Dec 17 2021 | Brief amicus curiae of Pacific Legal Foundation filed.Dec 20 2021 | Brief of petitioner Xiulu Ruan filed (in 20-1410).Dec 20 2021 | Joint appendix filed (in 20-1410). (Statement of costs filed)Dec 20 2021 | Joint appendix filed (in 21-5261). (Statement of costs filed)Dec 20 2021 | Brief of petitioner Shakeel Kahn filed (in 21-5261).Dec 21 2021 | Record requested from the U.S.C.A. 11th Circuit.Dec 21 2021 | Brief amicus curiae of Compassion & Choices filed (also in 21-5261). VIDED.Dec 23 2021 | Brief amici curiae of Professors of Health Law and Policy filed.Dec 27 2021 | Brief amicus curiae of Due Process Institute filed.Dec 27 2021 | Brief amicus curiae of Cato Institute filed.Dec 27 2021 | Brief amici curiae of Association of American Physicians and Surgeons and Jeffrey A. Singer, M.D. filed.Dec 27 2021 | Brief amicus curiae of National Pain Advocacy Center filed (also in 21-5261). VIDED.Dec 27 2021 | Brief amicus curiae of National Association of Chain Drug Stores in support of neither party filed (also in 21-5261) VIDED.Dec 27 2021 | Brief amicus curiae of Chamber of Commerce of the United States of America in support of neither party filed (also in 21-5261). VIDED.Dec 27 2021 | Brief amicus curiae of National Association of Criminal Defense Lawyers filed (also in 21-5261). VIDED.Dec 27 2021 | Brief amicus curiae of Anmol Singh Kamra filed (also in 21-5261). VIDED.Dec 27 2021 | Brief amici curiae of Stephen J. Ziegler, et al. filed.Dec 28 2021 | Amicus brief of Physicians Against Abuse submitted.★ Support this podcast on Patreon ★

We discuss the proposed changes to the CDC opioid prescribing guidelines and challenge the false notions around opioids, prohibition, and addiction. Dr. Singer shares the wisdom of his experiences as he discusses America's long history of struggling to understand addiction. Dr. Jeffrey A. Singer is a senior fellow at the Cato Institute and works in the Department of Health Policy Studies. He is President Emeritus and founder of Valley Surgical Clinics, the largest and oldest group private surgical practice in Arizona, and has been in private practice as a general surgeon for more than 35 years. He is a steadfast advocate for clinically sound drug policies, particularly that of harm reduction. https://www.cato.org/people/jeffrey-singer https://fedsoc.org/contributors/jeffrey-singer

Dr Singer discusses COVID variants, treatment drugs, opioid myths, DopeSick, etc

This episode is also available as a blog post: https://youarewithinthenorms.com/2021/11/08/jeff-a-singer-md-vs-samuel-quinones-author-jeffrey-a-singer-md-hulus-dopesick-quinones-dreamland-revives-a-false-narrative-and-pain-patients-may-suffer/ --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app Support this podcast: https://anchor.fm/norman-j-clement/support

“If public health officials want to change behavior, they need to start treating unvaccinated Americans with respect. Adopt consistent, transparent, respectful, and persuasive messaging. Give unvaccinated Americans the facts and let them choose for themselves.” ~ Jeffrey A. Singer & Michael F. Cannon

While the news cycle is focused on Covid-19, there is another epidemic sweeping America. Drug overdose deaths continue to rise and a fresh perspective is urgently needed. Two experts in the field, Jeffrey A. Singer, MD, F.A.C.S. and Dr. Kris Ferguson, MD discuss what is and isn't working in America, and what other countries have done to bring this epidemic under control. This episode of the Get Healthy 360 will challenge your views on drugs, drug users, the role of government, how we got here, and how we should proceed. Jeffrey A. Singer, MD is a Senior Fellow at the Cato Institute and works in the Department of Health Policy Studies. He is principal and founder of Valley Surgical Clinics, Ltd., the largest and oldest group private surgical practice in Arizona, and has been in private practice as a general surgeon for more than 35 years.

A surgeon and policy analyst tallies up the steep costs of delaying and denying elective surgery and other care during the coronavirus pandemic.

November 2019 featuring Jeffrey A. Singer, Clark Neily, Caleb O. Brown, Hon. Thomas Hardiman, Tom Mueller, Frank Dikötter, Rick Scott See acast.com/privacy for privacy and opt-out information.

Naloxone—an opioid antagonist that reverses overdoses—is a safe, effective, critical tool for preventing opioid-overdose deaths. The U.S. Food and Drug Administration nevertheless continues to require a prescription for each naloxone purchase, an unnecessary requirement that limits access to this life-saving drug.On October 2, the Cato Institute will hold a two-part Capitol Hill Briefing to discuss how naloxone can save even more lives. First, Cato senior fellow Jeffrey A. Singer and Cato adjunct scholar David A. Hyman will discuss the effectiveness of naloxone and the effect of, and reasons for, the FDA’s prescription requirement. Second, the Washington, DC, Department of Health will conduct naloxone training for all willing adult attendees and will distribute easy-to-use Narcan, a nasal-spray version of naloxone, to those who complete the training.Attending this event could help you save a life. We encourage each congressional office to designate at least one staffer to attend this event, train in naloxone administration, and keep this life-saving drug on hand anywhere someone may need it. See acast.com/privacy for privacy and opt-out information.

Harm Reduction: Shifting from a War on Drugs to a War on Drug‐​Related Deaths, Policy Analysis By Jeffrey A. Singer The U.S. government’s current strategy of trying to restrict the supply of opioids for nonmedical uses is not working. While government efforts to reduce the supply of opioids for nonmedical use have reduced the volume of both legally manufactured prescription opioids and opioid prescriptions, deaths from opioid overdoses are nevertheless accelerating. Research shows the increase is due in part to substitution of illegal heroin for now harder-to-get prescription opioids. Attempting to reduce overdose deaths by doubling down on this approach will not produce better results. Policymakers can reduce overdose deaths and other harms stemming from nonmedical use of opioids and other dangerous drugs by switching to a policy of “harm reduction” strategies. Harm reduction has a success record that prohibition cannot match. It involves a range of public health options. These strategies would include medication-assisted treatment, needle-exchange programs, safe injection sites, heroin-assisted treatment, deregulation of naloxone, and the decriminalization of marijuana. Though critics have dismissed these strategies as surrendering to addiction, jurisdictions that have attempted them have found they significantly reduce overdose deaths, the spread of infectious diseases, and even the nonmedical use of dangerous drugs.

New data is revealing that the doctor-centered narratives on opioid addiction and overdose are, at best, severely flawed and possibly entirely wrong. Jeffrey A. Singer describes why. See acast.com/privacy for privacy and opt-out information.

Dr. Jeffrey A. Singer discusses the four myths of the ongoing opioid crisis. To learn more, please visit: https://www.cato.org/people/jeffrey-singer.

Jeffrey A. Singer joins us this week to talk about the ongoing opioid overdose epidemic in the United States. Why are there so many opioid users in the US?Specifically, what kinds of drugs are we talking about, fentanyl? Oxycontin? Is the overdose death problem a direct result of doctors over-prescribing opiates to patients for pain management?Show Notes and Further ReadingHere’s a Cato briefing event that features Singer: “A ‘Modern Plague’? How the Federal Government Should Address the Opioid Crisis.””Misdiagnosing the Opioid Crisis”; this article appeared in Inside Sources on September 27, 2017.Trevor mentions Jacob Sullum’s book Saying Yes: In Defense of Drug Use (2004).Listeners may also be interested in our Free Thoughts episode with Johann Hari, “Chasing the Scream: The First and Last Days of the War on Drugs.” See acast.com/privacy for privacy and opt-out information.

In today's episode, host Marc Clair is welcomes in Dr. Jeffrey A. Singer - a physician, columnist, and political activist. Dr. Singer is an adjunct scholar with the CATO Institute, has written extensively on the government's role in the health care industry, and has been heavily involved in political action to limit this role for much of his career. Dr. Singer details why he ended up pursuing the medical profession and how this pursuit ended up coinciding with his burgeoning libertarian philosophy. Marc and Jeffrey then discuss the many ways in which government regulations and legislation have influenced the medical profession, and they dig beneath the surface to attempt to identify the root causes of just how the government has killed the medical profession.  [...] Learn more about your ad choices. Visit megaphone.fm/adchoices

In today’s episode, host Marc Clair is welcomes in Dr. Jeffrey A. Singer - a physician, columnist, and political activist. Dr. Singer is an adjunct scholar with the CATO Institute, has written extensively on the government’s role in the health care industry, and has been heavily involved in political action to limit this role for much of his career. Dr. Singer details why he ended up pursuing the medical profession and how this pursuit ended up coinciding with his burgeoning libertarian philosophy. Marc and Jeffrey then discuss the many ways in which government regulations and legislation have influenced the medical profession, and they dig beneath the surface to attempt to identify the root causes of just how the government has killed the medical profession.  [...]